Nuclear power specialist Holtec Nuclear has officially initiated its path to the public markets, filing documents with the Securities and Exchange Commission on Friday. The company plans to trade under the symbol HNUC, signaling a major expansion strategy as it prepares to list on both Nasdaq and Nasdaq Texas.
Investors pushed Q32 Bio shares up 38% to $15.47 in after-hours trading Friday, betting on the clinical-stage firm’s upcoming report. The company is set to release data Monday at 8:00 a.m. ET regarding a trial of bempikibart, an immunotherapy treatment designed to combat severe alopecia areata.
Mark Oswald, the chief financial officer of automotive-seating manufacturer Adient, will vacate his position no later than December 31. The company confirmed the executive's departure in a Friday filing with the Securities and Exchange Commission, noting that the move follows a formal notification submitted by Oswald on July 6.
A miscalculation in bridge loan commitment costs has forced Worthington Steel to restate its fourth-quarter earnings. The steel processor now reports a loss of $1.15 per share, an increase from the 98 cents previously disclosed on June 24, following the discovery of additional long-lived asset impairment charges.
Veraxa Biotech has appointed Carl von Halem as its interim chief financial officer, filling the vacancy left by outgoing executive Torsten Bürgermeister. The clinical-stage biotechnology firm confirmed it is currently finalizing negotiations with a candidate to fill the permanent position following a period of leadership transition.
Fastenal shareholders are set for a pay raise, as the industrial distributor confirmed an 8.3% hike to its quarterly cash dividend. The increase brings the per-share payout to 26 cents, up from the previous 24-cent mark, reflecting the company’s ongoing strategy to return capital to its investors.
Targeting a public debut to fund the final push for its flagship respiratory therapy, Boston-based Apnimed filed paperwork with the Securities and Exchange Commission on Friday. The company, which specializes in pharmacological treatments for obstructive sleep apnea, aims to secure capital for the commercialization of its lead candidate, Oxnimbi.
Facing a critical business combination with Clean World Ventures, SOBRsafe is pivoting away from its core hardware and software operations. The company plans to cease all alcohol-monitoring services by July 31, a move designed to preserve essential capital and streamline its balance sheet before the transition to a new corporate structure.
Christine Gorjanc has assumed the role of independent chair at Forward Air, stepping into the position following the sudden resignation of Jerome Lorrain from his executive chairmanship. The transition, disclosed in a Friday filing with the Securities and Exchange Commission, marks a shift in the transportation provider's leadership structure.
Energy sector shares ticked upward as market participants tracked the uncertain status of the U.S.-Iran peace agreement. While oil futures experienced a marginal decline, the broader outlook remains tethered to the stability of the Strait of Hormuz, where shipping activity has decelerated following recent armed skirmishes between the two nations.
A surge in metal and grain production signals a shift in market sentiment, as investors increasingly bet against widespread expectations of Federal Reserve interest rate hikes. While gold remains stagnant under the pressure of potential policy tightening, agricultural commodities are climbing on the back of historic supply shortages.
Patients diagnosed with muscle-invasive bladder cancer now have a broader treatment path as the FDA authorized a combination of Merck’s Keytruda and the Pfizer-Astellas drug Padcev. The decision marks a shift in standard care, extending the therapy's reach to those who are eligible for traditional cisplatin-based chemotherapy.
Seeking to expand its aviation-focused staffing operations, Cayman Islands-based Timwood Holdings filed for an initial public offering on Friday. The company aims to raise up to $28.4 million by selling 5.6 million units, with plans to list its shares on the Nasdaq Capital Market under the ticker symbol TIWD.
The Monroe Energy refinery in Trainer, Pennsylvania, is running at 75% capacity following a June 25 fire, with operational disruptions set to persist through the third quarter. Delta Air Lines CFO Erik Snell confirmed the outage trimmed 5 cents per share from the airline’s second-quarter financial results.
Persistent Ukrainian drone strikes against Russian refineries have crippled domestic output, forcing total refined product exports down to a record-low 1.9 million barrels per day in June. The International Energy Agency reports this collapse in supply is tightening margins across the Atlantic Basin as Russia faces mounting fuel shortages.
A landmark legal challenge brought by 1.6 million U.K. vehicle owners against several global automakers has largely collapsed. The High Court of England and Wales ruled Friday that it found no merit in the majority of allegations claiming manufacturers utilized illegal devices to bypass diesel emission-control regulations during real-world driving.
A 16% surge in EquipmentShare.com stock on Friday morning signaled a sudden shift in market sentiment, as the construction equipment provider announced an aggressive $500 million share-repurchase program alongside a significant lift to its full-year financial outlook for 2026.
A high court ruling in England and Wales has dealt a significant blow to a mass claim involving 1.6 million drivers, who accused major automakers of installing illegal devices to bypass diesel emission controls. The judge dismissed the majority of allegations against companies including Ford, Renault, and Mercedes-Benz.
A landmark legal battle involving 1.6 million vehicle owners suffered a major setback on Friday as the High Court of England and Wales rejected the bulk of allegations against several global automakers. The suit accused major manufacturers of installing illicit devices to bypass nitrogen oxide emission limits during real-world driving.
Tensions between the U.S. and Iran have cooled slightly, pushing crude oil and refined product futures into a second consecutive day of losses. Despite the current dip, the market remains on track for significant weekly gains as traders weigh the fragile state of regional peace negotiations against persistent supply concerns.
European competition regulators have cleared the $14 billion acquisition of Chart Industries by oil-services giant Baker Hughes, provided the companies divest specific business segments. The decision addresses concerns that the merger could create an unfair market advantage in the liquefied natural gas sector by restricting access to critical technology.
Altius Minerals is moving to consolidate its clean-energy portfolio, striking a deal to elevate its effective interest in Great Bay Renewables to 50 percent. This restructuring involves a complex exchange of assets between Altius and Northampton Capital Partners, effectively ending Apollo Global Management’s involvement in the platform.
Toronto-based DRI Healthcare Trust is liquidating its royalty interest in the drug Ekterly, securing a $178 million payout following the successful acquisition of KalVista Pharmaceuticals by Chiesi Group. The firm triggered a contractual put option to finalize the exit, marking a significant shift in its portfolio strategy.
Barnes & Noble Education shares surged 6% to $12.13 following a fiscal 2026 report that marked a definitive turn toward profitability. The company posted $16.9 million in annual income, a sharp recovery from the $65.8 million loss recorded in the previous year as revenues climbed steadily across its retail footprint.
A 14% surge in Cadiz shares followed the U.S. Bureau of Land Management’s decision to authorize a right-of-way grant for the Northern Pipeline. This critical federal approval unlocks the conversion of existing natural gas infrastructure into a water conveyance system, marking a turning point for the company’s regional operations in the drought-stricken Southwest.
Investors pushed Cue Biopharma shares up 6.7% Friday morning, reaching $38.95 after the biotechnology firm announced a $50 million private placement. The financing deal, which includes a mix of common stock and pre-funded warrants, marks a significant capital infusion for the company following a 157% stock rally over the last three months.
Chicago Fed President Austan Goolsbee warns that global central banks face a recurring dilemma: government fiscal spending often works at cross-purposes with monetary tightening. As inflation persists, the collision between expansionary budgets and interest rate hikes risks leaving policymakers behind the curve, a friction currently acute in the Japanese economy.
John Blank, a veteran of Caldwell Partners International since 2014, has been elevated to the role of chief operating officer. He will now balance his new oversight of the firm’s global operations with his ongoing responsibilities as a managing partner within the company’s Life Sciences and Healthcare Practice.
Neil Adler, a veteran financial executive who previously led the finance departments at Zimmer Financial Services Group and Zimmer Partners, has been named the new chief financial officer of Ategrity Speciality Insurance. He succeeds Neelam Patel, whose employment contract the firm chose not to renew this week.
A sharp contraction in construction activity dragged Mexico’s industrial output down by 0.8% in May, reversing the steady momentum gained during the previous month. Data released by the national statistics institute, Inegi, reveals a broad-based cooling across the sector, with mining and manufacturing also posting marginal losses.
